Skip to content

ழ தொலைக்காட்சி

HOME
NEWS
SPORT
ECONOMY
BUSINESS
POLITICS

Syndax wins FDA approval for leukemia drug revumenib

Syndax wins FDA approval for leukemia drug revumenib

November 16, 2024 by David Sch

Syndax wins FDA approval for leukemia drug revumenib

Categories BUSINESS Tags approval, Drug, FDA, leukemia, revumenib, Syndax, wins

Mom, 30, was ‘clinically dead’ for 45 minutes. When she woke, she found out she gave birth to triplets

Northern Ireland 2-0 Belarus: ‘We’ve got a lot of captains on that pitch’ – Charles

Leave a Comment Cancel reply

Comment

Name Email Website

Save my name, email, and website in this browser for the next time I comment.

Search for:

Recent Posts

How Russia plotted to mix a deadly new weapon among decoy drones in Ukraine
Trump’s victory will change America. But Europe can have a different future
Tech firm Palantir spoke with MoJ about calculating prisoners’ ‘reoffending risks’ | Palantir
Gerard Piqué might have found the perfect sport for Gen Z’s falling attention span
Jake Paul defeats Mike Tyson by unanimous decision
DelphX announces non-brokered unit private placement
An Indian family froze to death crossing the Canada-US border, a perilous trip becoming more common
LeBron James, 39 years young, records career-best 4th straight triple-double

Categories

BUSINESS
ECONOMY
NEWS
POLITICS
SCIENCE
SPORT
Uncategorized
WORLD ES
WORLD-EN

© 2024 ழ தொலைக்காட்சி • Built with GeneratePress